Measurable residual disease (MRD) status is a critical prognostic indicator in both newly diagnosed and relapsed multiple myeloma (MM), with persistent MRD linked to poorer survival outcomes.

Read More> https://multiplemyeloma.pocn.com/patient-management/serial-measurable-residual-disease-monitoring-found-to-improve-prognosis-and-treatment-in-multiple-myeloma/